Sm. Chuang et al., Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity, CARCINOGENE, 21(8), 2000, pp. 1491-1500
In this study we have explored the involvement of oxidative stress in Cr(VI
)-induced JNK, p38 and ERK signaling pathways and their effects on Cr(VI) c
ytotoxicity in human non-small cell lung carcinoma CL3 cells. Exposure to K
2Cr2O7 markedly activated JNK and p38 and moderately activated ERK in a dos
e- (10-80 mu M) and time-dependent (1-12 h) manner. The activated p38 decre
ased markedly and rapidly and the activated JNK decreased gradually when Cr
(VI) was removed from the medium. Post-incubation of Cr(VI)-treated cells w
ith H2O2 increased the activities of JNK and p38, but not ERK, Go-administe
ring Cr(VI) with 3-amino-1,2,4-triazole (3AT), a catalase inhibitor, enhanc
ed p38 activation, but did not influence JNK and ERK activation by Cr(VI),
Conversely, co-administering Cr(VI) with mannitol, a hydroxyl radical scave
nger and a Cr(V) chelator, reduced p38 activation and increased JNK and ERK
activation by Cr(VI), These results indicate that p38 activation by Cr(VI)
is positively correlated with oxidative stress, while JNK activity can be
enhanced by either a quencher (mannitol) or activator (H2O2) of redox react
ions in Cr(VI)-exposed CL3 cells. However, both 3AT and mannitol reduced th
e cytotoxicity of Cr(VI), but H2O2 did not. The JNK activated by Cr(VI) was
decreased (similar to 50%) by expression of a kinase-defective form of MKK
7 (MKK7A) but not that of MKK4 (MKK4KR), suggesting that activation of JNK
by Cr(VI) is mediated through MKK7, SB202190, a specific inhibitor of p38,
markedly decreased JNK but did not change ERK activation by Cr(VI), PD98059
, a specific inhibitor of ERK kinases MKK1/2, blocked ERK and p38 but did n
ot alter JNK activation by Cr(VI), Neither the specific kinase inhibitors n
or expression of MKK7A altered Cr(VI)-induced cytotoxicity, Together, these
results suggest that activation of the JNK, p38 and ERK pathways by Cr(VI)
is mediated through diverse redox mechanisms, yet their activation does no
t correlate with Cr(VI) cytotoxicity.